Načítá se...
Medical interventions for the prevention of platinum‐induced hearing loss in children with cancer
BACKGROUND: Platinum‐based therapy, including cisplatin, carboplatin, oxaliplatin or a combination of these, is used to treat a variety of paediatric malignancies. One of the most significant adverse effects is the occurrence of hearing loss or ototoxicity. In an effort to prevent this ototoxicity,...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2019
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6504134/ https://ncbi.nlm.nih.gov/pubmed/31063591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009219.pub5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|